Personalized Gait Retraining to Support Knee Health in Older Adults (BiofeedbackRCT)
A Real-time Biofeedback Intervention for Improving Tibiofemoral Cartilage Quality in Older Adults
Participants are randomized into two groups: gait retraining and habitual walking. In the gait retraining group, an intervention consisting of 10 training sessions on a treadmill aims to reduce medial tibiofemoral joint loading during walking. Real-time visual biofeedback on a knee joint loading metric is provided during some of the training sessions to facilitate learning. The habitual walking group participates in an equal number of training sessions where they perform their habitual walking and do not try to change their walking technique. Changes in knee joint cartilage properties are assessed at 5 months.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
In this randomized controlled intervention study, participants are randomized into two groups: gait retraining and habitual walking. At baseline and five months later, participants' gait mechanics and knee joint cartilage structure and quality are assessed, and blood and urine samples and questionnaire data are collected. In addition, knee joint radiographic status is assessed at baseline. Physical activity is monitored using a thigh-worn accelerometer throughout the study.
The intervention consisting of 10 training sessions on a treadmill aims to reduce medial tibiofemoral joint loading during walking. During the first session, participants try different kinematics-based gait modifications to personalize the intervention. The modifications that reduce estimated medial tibiofemoral knee joint loading the most are selected and utilized during the following sessions. The gait retraining aims at establishing a gait pattern for each individual that reduces medial tibiofemoral joint loading while also being such that the person can utilize it in their daily living. To support learning and fine-tuning the gait pattern, real-time feedback on knee joint moments is provided during part of the training sessions. The habitual walking group participates in an equal number of training sessions where they perform their habitual walking and do not try to change their walking technique. Eight of the training sessions are conducted within four weeks, while the two remaining sessions (so-called boosters) are conducted during the following four months with the aim of supporting maintenance of the learned gait pattern.
Pre-planned additional follow-ups are planned for 12 and 24 months from baseline. Knee MRI would be conducted at these follow-up points, with implementation depending on funding.
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Lauri Stenroth, PhD
- Numero di telefono: +358505649096
- Email: lauri.stenroth@uef.fi
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Age above 65 or below 75 years (in full years)
- Access to a smartphone or tablet with an Android or iOS operating system
Exclusion Criteria:
- Unable to walk for 30 minutes without stopping and without an assistive device
- Body mass index <18 or >30 kg/m2
- Pain during walking
- Diagnosed with knee osteoarthritis
- Moderate (KL Grade 3) or severe (KL Grade 4) radiographical tibiofemoral osteoarthritis based on Kellgren-Lawrence (KL) Classification of Osteoarthritis
- Diagnosed with neurological disease
- Surgery of the knee joint
- Surgery or injury to the lower limbs causing pain or affecting mobility
- Current musculoskeletal injury causing pain or affecting mobility
- Contraindication for magnetic resonance imaging
- Contraindication for walking-based exercise training (e.g., cardiovascular symptoms that increase with exercise or recommendation from a medical professional to avoid moderate exercise)
- Any other condition that, in the opinion of the investigator, makes a potential participant unfit for participation or conditions that put a potential participant at risk by participation
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Scienza basilare
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: Gait retraining
The arm receives personalized gait retraining via treadmill walking and real-time feedback. |
Personalized gait retraining using small kinematic alterations guided by real-time feedback of knee joint loading. The training is perfomed on a treadmill. |
|
Altro: Habitual walking
The arm receives equal amount of treadmill walking without feedback or instruction to alter the gait. |
Participants receive equal amount of treadmill walking as the ones receiving gait retraining intervention. This intervention serves as the comparator for the gait retraining intervention. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Medial tibiofemoral T1ρ relaxation time
Lasso di tempo: Baseline and 5 months
|
T1ρ relaxation time map of tibiofemoral cartilage from the medial compartment of the knee joint assessed using 3T MRI |
Baseline and 5 months
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Medial tibiofemoral T2 relaxation time
Lasso di tempo: Baseline and 5 months
|
T2 relaxation time map of tibiofemoral cartilage from the medial compartment of the knee joint assessed using 3T MRI |
Baseline and 5 months
|
|
Lateral tibiofemoral T1ρ relaxation time
Lasso di tempo: Baseline and 5 months
|
T1ρ relaxation time map of tibiofemoral cartilage from the lateral compartment of the knee joint assessed using 3T MRI |
Baseline and 5 months
|
|
Lateral tibiofemoral T2 relaxation time
Lasso di tempo: Baseline and 5 months
|
T2 relaxation time map of tibiofemoral cartilage from the lateral compartment of the knee joint assessed using 3T MRI |
Baseline and 5 months
|
|
Tibiofemoral loading during walking
Lasso di tempo: Baseline and 5 months
|
Tibiofemoral loading during walking assessed using musculoskeletal simulation |
Baseline and 5 months
|
|
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Lasso di tempo: Baseline and 5 months
|
The score range is from 0 to 100. 0 represents extreme problems / worst possible knee symptoms. 100 represents no problems / perfect knee health. |
Baseline and 5 months
|
Altre misure di risultato
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
High-sensitivity C-reactive protein (hs-CRP)
Lasso di tempo: Baseline and 5 months
|
hs-CRP (mg/L) is measured from blood samples using a particle-enhanced immunoturbidimetric assay as a marker of systemic inflammation. |
Baseline and 5 months
|
|
Glycated hemoglobin (HbA1c)
Lasso di tempo: Baseline and 5 months
|
HbA1c (mmol/mol) is measured from blood samples using turbidimetric inhibition immunoassay as a marker of long-term blood glucose control. |
Baseline and 5 months
|
|
Knee cartilage recovery rate after loading assessed from magnetic resonance images
Lasso di tempo: Baseline and 5 months
|
The knee joint is loaded with 20 minutes of standing and followed by repeated magnetic resonance imaging. Cartilage is segmented from the images, and the temporal recovery of the cartilage thickness in the medial tibiofemoral joint is quantified. The unit is mm/min. |
Baseline and 5 months
|
|
Proteomic analysis of serum samples
Lasso di tempo: Baseline and 5 months
|
Liquid chromatography-mass spectrometry is used to run non-targeted peptide analysis of serum proteins. This is a pre-planned exploratory analysis that identifies hundreds of proteins and their concentration in the sample. |
Baseline and 5 months
|
Collaboratori e investigatori
Sponsor
Sponsor
Collaboratori
Collaboratori
Investigatori
Investigatori
- Investigatore principale: Lauri Stenroth, PhD, University of Eastern Finland
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- 125/2025
- 363854 (Altro numero di sovvenzione/finanziamento: Research Council of Finland)
- FIMEA/2025/007528-5 (Altro identificatore: Finnish Medicines Agency)
- 125/2025 (Altro identificatore: The Regional Medical Research Ethics Committee of Eastern Finland Collaborative Area)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
IPD used in the publications is planned to be shared.
Periodo di condivisione IPD
At the time of publication with no end date.
Criteri di accesso alla condivisione IPD
Open access to the IPD and supporting information to be used in scientific research. If possible, the data is made available at the time of publishing the results with link to the data repository at the publication.
Tipo di informazioni di supporto alla condivisione IPD
- STUDIO_PROTOCOLLO
- LINFA
- ICF
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .